Literature DB >> 15710225

The origin of quasispecies: cause or consequence of chronic hepatitis C viral infection?

David G Bowen1, Christopher M Walker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15710225     DOI： 10.1016/j.jhep.2004.12.013

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  17 in total

1.  Unique Cytokine/Chemokine Signatures for HIV-1 and HCV Mono-infection versus Co-infection as Determined by the Luminex® Analyses.

Authors:  Saifur Rahman; John E Connolly; Sharron L Manuel; Jihed Chehimi; Luis J Montaner; Pooja Jain
Journal:  J Clin Cell Immunol       Date:  2011-01-07

2.  Genome-Wide Mutagenesis of Hepatitis C Virus Reveals Ability of Genome To Overcome Detrimental Mutations.

Authors:  Deepak Singh; Shalini Soni; Shaheen Khan; Aditya N Sarangi; Ragothaman M Yennamalli; Rakesh Aggarwal; Naga Suresh Veerapu
Journal:  J Virol       Date:  2020-01-17       Impact factor: 5.103

3.  Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes.

Authors:  Nicasio Mancini; Roberta A Diotti; Mario Perotti; Giuseppe Sautto; Nicola Clementi; Giovanni Nitti; Arvind H Patel; Jonathan K Ball; Massimo Clementi; Roberto Burioni
Journal:  PLoS One       Date:  2009-12-11       Impact factor: 3.240

4.  High levels of subgenomic HCV plasma RNA in immunosilent infections.

Authors:  Flavien Bernardin; Susan L Stramer; Barbara Rehermann; Kimberly Page-Shafer; Stewart Cooper; David R Bangsberg; Judith Hahn; Leslie Tobler; Michael Busch; Eric Delwart
Journal:  Virology       Date:  2007-05-09       Impact factor: 3.616

Review 5.  Underlying pathophysiology of HCV infection in HIV-positive drug users.

Authors:  Anuradha Balasubramanian; Jerome E Groopman; Ramesh K Ganju
Journal:  J Addict Dis       Date:  2008

6.  Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus.

Authors:  Rodney S Russell; Jean-Christophe Meunier; Shingo Takikawa; Kristina Faulk; Ronald E Engle; Jens Bukh; Robert H Purcell; Suzanne U Emerson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-11       Impact factor: 11.205

7.  An unbalanced PD-L1/CD86 ratio in CD14(++)CD16(+) monocytes is correlated with HCV viremia during chronic HCV infection.

Authors:  Jiajia Zheng; Hua Liang; Chunhui Xu; Qiang Xu; Ting Zhang; Tao Shen; Fengmin Lu
Journal:  Cell Mol Immunol       Date:  2014-02-17       Impact factor: 11.530

8.  Hepatitis C virus NS5B protein delays s phase progression in human hepatocyte-derived cells by relocalizing cyclin-dependent kinase 2-interacting protein (CINP).

Authors:  Yaohui Wang; Yuchan Wang; Yan Xu; Wenyan Tong; Tingting Pan; Jianhua Li; Shuhui Sun; Junjie Shao; Huanping Ding; Tetsuya Toyoda; Zhenghong Yuan
Journal:  J Biol Chem       Date:  2011-05-31       Impact factor: 5.157

Review 9.  Mechanisms of viral emergence.

Authors:  Esteban Domingo
Journal:  Vet Res       Date:  2010-02-05       Impact factor: 3.683

10.  Evolution of hepatitis C virus NS5A region in breakthrough patients during pegylated interferon and ribavirin therapy*.

Authors:  H J Yuan; M Jain; K K Snow; M Gale; W M Lee
Journal:  J Viral Hepat       Date:  2009-07-28       Impact factor: 3.728
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.